Pfizer Awards Grant to UC Riverside Researchers for Discovery of IBD Therapeutic Target
News
Pfizer has awarded $150,000 to Declan McCole, PhD, and his team to find a therapeutic target for correcting intestinal barrier defects for patients with inflammatory bowel disease (IBD) who have mutations in the ... Read more